Please try another search
BJ's Wholesale Club (BJ) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended January 2020. This widely-known consensus outlook...
The market expects Canadian Natural Resources (CNQ) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2019. This widely-known...
Cantel Medical (CMD) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended January 2020. This widely-known consensus outlook...
Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when BioCryst Pharmaceuticals (BCRX) reports results for the quarter ended December 2019. While this widely-known...
American Outdoor Brands (AOBC) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended January 2020. This widely-known consensus...
Wall Street expects a year-over-year decline in earnings on higher revenues when AcelRx Pharmaceuticals (ACRX) reports results for the quarter ended December 2019. While this widely-known consensus...
Investors might want to bet on Watford Holdings (WTRE), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum,...
What is an “investment”? How do you define it? I think this is an important question to answer because many of those who consider themselves investors today are really just speculators, in...
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Veeva Systems...
The coronavirus outbreak has spread worldwide, with confirmed cases in more than 40 countries. The situation has raised fears of pandemic, wiping out around $1.7 trillion from the U.S. stock market in...
Investors might want to bet on Nautilus (NLS), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of...
CytomX Therapeutics (CTMX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates --...
BWX Technologies (BWXT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates --...
CrossFirst Bankshares (CFB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings...
Cidara Therapeutics (CDTX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates...